Mode
Text Size
Log in / Sign up
N/A N=30 Treatment

Prospective Clinical Evaluation of High-Purity Type I Collagen in Select High-Risk Hernia Repair Scenarios

Hernia · Ventral Hernia · Incisional Hernia · İnguinal Hernia · Abdominal Wall Hernia

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Number of Participants With Early Postoperative Safety Events (Surgical Site Infection, Mesh-Related Adverse Events, or Reoperation) — 4; 0; 0; 0 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
High-Purity Type I Collagen Mesh (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Adichunchanagiri Institute of Medical Sciences, B G Nagara
Primary completion
Mar 2026

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Early Postoperative Safety Events (Surgical Site Infection, Mesh-Related Adverse Events, or Reoperation)
4; 0; 0; 0; 0
SECONDARY
Number of Participants With Early Wound Complications (Seroma, Hematoma, or Wound Dehiscence)
2; 0; 0
SECONDARY
Postoperative Change in Visual Analog Scale (VAS) Pain Scores
6.0; 4.1; 3.4; 2.9
SECONDARY
Early Clinical Integrity of Repair
30; 0; 0; 0
SECONDARY
Length of Hospital Stay
3.2
SECONDARY
Patient Satisfaction With Hernia Repair
16; 11; 3; 0; 0
SECONDARY
Hernia-Specific Quality of Life
42; 21

Summary

This prospective, single-arm clinical study evaluates the safety, feasibility, and early clinical outcomes of High-Purity Type I Collagen (HPTC; Surgicoll-Mesh®) when used as a biologic reinforcement in selected hernia repair scenarios where permanent synthetic mesh placement is undesirable. Outcomes focus on early postoperative safety, wound healing, and complication profiles over an 8-week follow-up period.

Eligibility Criteria

Inclusion Criteria

  • Age ≥18 years
  • Ventral, incisional, umbilical, or para-umbilical hernia
  • Contaminated or potentially contaminated surgical field
  • Hernia repair following infected mesh explantation
  • High-risk patients (diabetes, obesity, smoking, immunosuppression)
  • Ability to provide informed consent

Exclusion Criteria

  • Clean, low-risk primary hernia suitable for synthetic mesh
  • Large defects requiring permanent load-bearing prosthesis
  • Generalized peritonitis or uncontrolled sepsis
  • Known collagen hypersensitivity
  • Pregnancy
  • Inability to comply with follow-up
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT07360691). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search